MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLIBX40.500.36
+0.90%
Plumb Balanced Institutional
VFSNX287.14-0.46
-0.16%
Vanguard FTSE All-Wld ex-US SmCp Idx Ins
RRRRX24.29-0.13
-0.53%
DWS RREEF Real Estate Securities Instl
GSAOX21.26-0.12
-0.56%
Goldman Sachs Small Cap Gr Insghts A
TRRPX20.29-0.13
-0.64%
Nuveen Real Estate Sec Sel Premier

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with IMUX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then IMUX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-3.39%
IMUX - IRD
37%
Loosely correlated
-0.14%
ARRY - IRD
35%
Loosely correlated
+2.76%
ROIV - IRD
35%
Loosely correlated
-1.77%
MGX - IRD
32%
Poorly correlated
-2.46%
AVBP - IRD
31%
Poorly correlated
-2.74%
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com